ADLAI NORTYE LTD. AMERICAN DEPOSITARY SHARES reports a Return on Equity (ROE) of 649.66%.

What is ANL's dividend yield?

ADLAI NORTYE LTD. AMERICAN DEPOSITARY SHARES offers a dividend yield of 0.00%.

What is ANL's Deepscope Quality Score?

Deepscope rates ANL's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ANL?

Deepscope's AI Timing Score for ANL is 55 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ANL belong to?

ADLAI NORTYE LTD. AMERICAN DEPOSITARY SHARES is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu ANL (NASDAQ) | ADLAI NORTYE LTD. AMERICAN DEPOSITARY SHARES

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-11 | FS: 2026-03-31)

ANL

ADLAI NORTYE LTD. AMERICAN DEPOSITARY SHARES

US:NASDAQ STOCK Healthcare >> Biotechnology News 90

USD 10.20

-0.27 (-2.58%) Day Change

Watchlist Portfolio Compare Chart

-3.03

D/E

649.7%

ROE

-157.0%

ROA

0.00%

Div Yield

Data partially updated

ADLAI NORTYE LTD. AMERICAN DEPOSITARY SHARES
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 10.20 Price -0.27 (-2.58%) Day Change	NEWS SCORE: 90

ANL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) và Thời điểm mua ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	90
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	10.20
PBV / Sector	-81.02 / 4.79
Earning Per Share	-0.82

PE / Sector	N/A / 18.05
PEG or PE/Growth / Sector	N/A / 0.62
Average 1M Daily Value	1.60 M GREAT
Average 1W Daily Value	1.37 M GREAT

Yếu tố Kỹ thuật

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-833.05 / 468.85
NPM Average (%) / Sector	-1,243.36 / -1,531.69
NPM Change Average (%) / Sector	N/A / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-157.02 / 31.69
ROA Average (%) / Sector	-99.57 / -353.18
ROA Change Average (%) / Sector	21.07 / 5,214.65 GREAT
ROE (%) / Sector	649.66 / 10.58 GREAT
ROE Average (%) / Sector	150.37 / 27.64 GREAT
ROE Change Average (%) / Sector	-228.78 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.77

Chi tiết đăng ký

Analyze Date	2026-06-12 09:43:24
Symbol	ANL
Name	ADLAI NORTYE LTD. AMERICAN DEPOSITARY SHARES
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	58.73 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	674.25 / 9,010.81

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: New Jersey Biotechnology Dev Ctr, North Brunswick, NJ, United States, 08902

Phone: 848 230 7430

Website: https://www.adlainortye.com

Employees: 109

Sector: Healthcare >> Biotechnology

Description: Adlai Nortye Ltd., a clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products. Its product pipeline comprises AN0025, a small molecule EP4 antagonist which is in phase Ib and radiotherapy/chemoradiotherapy combination for the treatment of rectum cancer and esophageal cancer; and phase II trial for patients with moderate to high-risk rectal cancer. The company also develops AN9025, an oral small molecule pan-RAS(ON) inhibitor, which is in phase 1a clinical trials for the treatment of RAS-mutant cancers, including pancreatic, lung, and colorectal adenocarcinomas; AN4035, a proprietary CEACAM5-targeting antibody drug conjugate designed to deliver potent anti-tumor activity with an improved therapeutic window; and AN8025, a tri-specific antibody fusion protein which is in phase Ia clinical trial to treat advanced tumors. In addition, it develops AN4005, a small-molecule PD-L1 inhibitor that demonstrates antitumor activity by the blockade of PD-1/PD-L1 interaction which is in phase 1b clinical trial to activate cancer immunity. Further, the company is involved in technology transfer and consulting services business. Adlai Nortye Ltd. was founded in 2004 and is headquartered in North Brunswick, New Jersey.